Bridging regenerative medicine based therapies into the 21st Century: solo or symphony?
暂无分享,去创建一个
Giuseppe Biondi-Zoccai | Isotta Chimenti | Luigi Frati | Mariangela Peruzzi | Giacomo Frati | L. Frati | G. Biondi‐Zoccai | G. Frati | A. Marullo | I. Chimenti | E. Greco | M. Peruzzi | E. Falco | Piergiusto Vitulli | Elena De Falco | Ernesto Greco | Antonino G.M. Marullo | P. Vitulli
[1] J. Villard,et al. Potential and Limitation of HLA-Based Banking of Human Pluripotent Stem Cells for Cell Therapy , 2014, Journal of immunology research.
[2] M. Sullivan. Banking on cord blood stem cells , 2008, Nature Reviews Cancer.
[3] E. Messina,et al. Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture , 2014, Journal of cellular and molecular medicine.
[4] D. Francis,et al. Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis , 2014, BMJ : British Medical Journal.
[5] V. Fineschi,et al. Stem cell therapy: from evidence-based medicine to emotion-based medicine? The long Italian way for a scientific regulation , 2013, Stem Cell Research & Therapy.
[6] Buket Aksu,et al. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[7] E. Messina,et al. Thrombin and thrombin-derived peptides promote proliferation of cardiac progenitor cells in the form of cardiospheres without affecting their differentiation potential. , 2011, Journal of biological regulators and homeostatic agents.
[8] L. Pierelli,et al. Optimization of the isolation and expansion method of human mediastinal–adipose tissue derived mesenchymal stem cells with virally inactivated GMP-grade platelet lysate , 2013, Cytotechnology.